Gascon_2016 - Residential green spaces and mortality: A systematic review

Basic Article Info:

Article key Gascon_2016
Title Residential green spaces and mortality: A systematic review
Year 2016
Review type systematic review
Main topic The association between long-term exposure to residential green and blue spaces and mortality in adults.
Subjects area(s) Environment and nature, Health and well-being
Built environment scale Urban area / Urban system
Application(s)
Geographically focused no
Prisma diagram used yes
Study focus start 2008
Study focus end 2014
Search string not provided
No. of original sources 12
Synthesis method quantitative
Quantitative map included yes
Conflict of interest not declared specifically
Comments Includes a statistical meta-analysis. No exact search string or the exact list of search terms are given.

 

Details about searches

Search sources No search sources found
Keywords used in search environment, test

 

Authorship

Authors
Name Email Organisation Address Country
Mireia Gascon* mgascon@creal.cat CIBER of Epidemiology and Public Health (CIBERESP) Barcelona 08036, Spain Spain
Mireia Gascon* mgascon@creal.cat ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Cli?nic-Universitat de Barcelona, Barcelona 08036, Spain Spain
Mireia Gascon* mgascon@creal.cat Parc de Recerca Biome?dica de Barcelona (PRBB) Centre for Research in Environmental Epidemiology (CREAL). Doctor Aiguader, 88, 08003 Barcelona, Catalonia, Spain Spain
Mireia Gascon* mgascon@creal.cat Department of Genes and Environment, Division of Epidemiology Norwegian Institute of Public Health, Oslo 0403, Norway Norway
Margarita Triguero-Mas mtriguero@creal.cat CIBER of Epidemiology and Public Health (CIBERESP) Barcelona 08036, Spain Spain
Margarita Triguero-Mas mtriguero@creal.cat Parc de Recerca Biome?dica de Barcelona (PRBB) Centre for Research in Environmental Epidemiology (CREAL). Doctor Aiguader, 88, 08003 Barcelona, Catalonia, Spain Spain
David Martinez dmartinez@creal.cat CIBER of Epidemiology and Public Health (CIBERESP) Barcelona 08036, Spain Spain
David Martinez dmartinez@creal.cat Parc de Recerca Biome?dica de Barcelona (PRBB) Centre for Research in Environmental Epidemiology (CREAL). Doctor Aiguader, 88, 08003 Barcelona, Catalonia, Spain Spain
Payam Dadvand pdadvand@creal.cat CIBER of Epidemiology and Public Health (CIBERESP) Barcelona 08036, Spain Spain
Payam Dadvand pdadvand@creal.cat Parc de Recerca Biome?dica de Barcelona (PRBB) Centre for Research in Environmental Epidemiology (CREAL). Doctor Aiguader, 88, 08003 Barcelona, Catalonia, Spain Spain
Joan Forns jforns@creal.cat CIBER of Epidemiology and Public Health (CIBERESP) Barcelona 08036, Spain Spain
Joan Forns jforns@creal.cat Parc de Recerca Biome?dica de Barcelona (PRBB) Centre for Research in Environmental Epidemiology (CREAL). Doctor Aiguader, 88, 08003 Barcelona, Catalonia, Spain Spain
Joan Forns jforns@creal.cat Department of Genes and Environment, Division of Epidemiology Norwegian Institute of Public Health, Oslo 0403, Norway Norway
Antoni Plasencia antoni.plasencia@isglobal.org ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Cli?nic-Universitat de Barcelona, Barcelona 08036, Spain Spain
Mark J. Nieuwenhuijsen mnieuwenhuijsen@creal.cat CIBER of Epidemiology and Public Health (CIBERESP) Barcelona 08036, Spain Spain
Mark J. Nieuwenhuijsen mnieuwenhuijsen@creal.cat Parc de Recerca Biome?dica de Barcelona (PRBB) Centre for Research in Environmental Epidemiology (CREAL). Doctor Aiguader, 88, 08003 Barcelona, Catalonia, Spain Spain

 

Funding

Funding sources No funding sources recorded


Article publication information:

Article type Journal article
Article category Text
Geographical scale International
Language English
Chapter or part
Conference date
Conference venue
Published date 2015-11-02
Edition
Issue
Journal Environment International
Pagination 60-67
Peer reviewed yes
Publication place
Publisher Elsevier Ltd.
School / department or centre
Series volume no.
Series title
Series sort no.
Volume 86
Website owner
Copyrights of article
Licences of article
Identifiers of article


Quality assessment

Quality measure Details Score Comments
QA question 1 Are the research questions and inclusion criteria for the review clearly delineated? 1 = “Yes” = Who (Population), What (Intervention, Comparator group, Outcome), Where and When described. general but concrete description of aims
QA question 2 Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review and did the report justify any significant deviations from the protocol? 0 = ”No” = research question and inclusion criteria not outlined in detail. not provided
QA question 3 Did the review authors explain their selection of the study designs for inclusion in the review? 0 =”No” = no explicit justification of the study designs/types included in the review. empirical studies
QA question 4 Did the review authors use a comprehensive literature search strategy? 0.5 = “Can’t answer / not sure / partially” = searched at least 2 databases (relevant to research question), provided key word and/or general search strategy, justified publication restrictions (e.g., language). 2 databases and references
QA question 5 Did the review authors perform study selection in duplicate? 1 = “Yes” = either ONE of the following: at least two reviewers independently agreed on selection of eligible studies and achieved consensus on which studies to include OR two reviewers selected a sample of eligible studies and achieved good agreement (at least 80%), with the remainder selected by one reviewer. Two independent reviewers involved
QA question 6 Did the review authors perform data extraction in duplicate? 1 = “Yes” = either ONE of the following: at least two reviewers achieved consensus on which data to extract from included studies OR two reviewers extracted data from a sample of eligible studies and achieved good agreement (at least 8 %), with the remainder extracted by one reviewer. Two independent reviewers involved
QA question 7 Did the review authors provide a list of excluded studies and justify the exclusions? 0 =”No” = No list of studies excluded at a full-text stage. not provided
QA question 8 Did the review authors describe the included studies in adequate detail? 1 = “Yes” = ALL the following: Who (Population), What (Intervention, Comparator group, Outcome), Where and When described in detail. TABLE 1, SI Table A
QA question 9 Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review? 0.5 = “Can’t answer / not sure / partially” = Cannot decide between “yes” and “no”, basing on the information provided in the paper. RoB mentioned or not sufficiently assessed (e.g. if multiple sources of bias potentially present, but not all assessed). partially via QA of individall studies (Supplemental material, Table A).
QA question 10 Did the review authors report on the sources of funding for the studies included in the review? 0 =”No” = no report of the sources of funding for individual studies included in the review. not provided
QA question 11 If meta-analysis was performed did the review authors use appropriate methods for statistical combination of results? 1 = “Yes” = The authors justified combining the data in a meta-analysis AND they used an appropriate technique to combine study results and adjusted for heterogeneity if present AND investigated the causes of any heterogeneity or adjusted for heterogeneity or confounding if present. rendom-effects model
QA question 12 If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis? 0 =”No” = no assessment of the potential impact of RoB. not provided
QA question 13 Did the review authors account for RoB in individual studies when interpreting/ discussing the results of the review? 0 =”No” = no discussion of the potential impact of RoB in individual studies. not provided
QA question 14 Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? 1 = “Yes” = There was no significant heterogeneity in the results OR if heterogeneity was present the authors performed an investigation of sources of any heterogeneity in the results and discussed the impact of this on the results of the review. discussed methodological factors
QA question 15 If they performed quantitative synthesis did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review? 1 = “Yes” = The authors performed graphical or statistical tests for publication bias and discussed the likelihood and magnitude of impact of publication bias. Funnel plots and the Egger tests
QA question 16 Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review? 1 = “Yes” = The authors reported no competing interests OR the authors described their funding sources and how they managed potential conflicts of interest. Funding sources and Dsiclosure Statement provided
Quality index Overall rating (Quality Index) assigned to each SR, highlighting whether major concerns arose during quality assessment that may affect overall conclusions of a SR: A = Minimal flaws; B = Some flaws; C = Major flaws in many aspects of the review. A no protocol, no list of excluded studies
Suggested review type Actual review type:systematic map, systematic review, rapid review, scoping review, narrative review, etc. meta-analysis N/A
Risk of bias level How likely are the main conclusions of the review to be biased? Basing on review type and quality index and quality_index_comment assign: high moderate or low risk? medium no protocol, no list of excluded studies